Kirsten is Executive Director of Marketing at Amgen Inc., a leading human therapeutics company in Southern California.   Most recently, Kirsten was Brand Lead for Prolia (denosumab), a first-in-class human monoclonal antibody for postmenopausal osteoporosis. Kirsten joined Amgen in 2004 as Senior Director of Enbrel Rheumatology Sales and Marketing, leading a team of over 100 Amgen sales and marketing professionals in a joint venture/co-promote structure with Wyeth Pharmaceuticals.  Prior to joining Amgen, Kirsten was with Bristol-Myers Squibb (BMS). From 2002-2004, she supervised the Plavix US primary care marketing team, in a joint venture with Sanofi-Synthelabo. Plavix prescriptions grew +30%, to $2.9 billion during Kirsten's tenure.  Kirsten began her career at BMS in 1991 with the Worldwide Consumer Medicines Division, working on OTC drugs including Excedrin, Bufferin, and Nuprin.  These consumer-marketing experiences formed the foundation for her subsequent career contributions in direct-to-consumer (DTC) advertising for Plavix, Vanlev, Enbrel, and Prolia.  Kirsten earned her Bachelor of Arts (BA) in chemistry from Middlebury College and her Master of Business Administration (MBA) from the Amos Tuck School of Business at Dartmouth College.

Sean Caffey,MD, has been CEO of Replenish, Inc. since co-founding the company in August 2007. He has over ten years of experience with medical device and drug delivery startup companies in ophthalmology and neurosciences. He holds an MBA from USC Marshall School of Business and MD from USC Keck School of Medicine. Sean previously worked as the Director of Business Development at the USC / Caltech Engineering Research Center for Biomimetic MicroElectronic Systems (BMES) where he recruited 18 medical and pharma companies to join the USC Medical School's BMES center since 2003. While on staff at the USC Keck School of Medicine and the USC Department of Biomedical Engineering, he was a part time employee for the US Army's Telemedicine and Advanced Technology Research Center (TATRC) where he represented the US Department of Defense to select and assist in commercializing innovative biomedical technologies for troops abroad.

Click here to see the full list of SoCalBio Board Members